CN102552698B - 铁皮石斛的药用用途 - Google Patents
铁皮石斛的药用用途 Download PDFInfo
- Publication number
- CN102552698B CN102552698B CN201210010975.3A CN201210010975A CN102552698B CN 102552698 B CN102552698 B CN 102552698B CN 201210010975 A CN201210010975 A CN 201210010975A CN 102552698 B CN102552698 B CN 102552698B
- Authority
- CN
- China
- Prior art keywords
- group
- aging
- herba dendrobii
- fresh
- model
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 241000026010 Dendrobium candidum Species 0.000 title description 2
- 239000003814 drug Substances 0.000 claims abstract description 31
- 210000004291 uterus Anatomy 0.000 claims description 33
- 210000004392 genitalia Anatomy 0.000 claims description 16
- 210000001550 testis Anatomy 0.000 claims description 11
- 210000001625 seminal vesicle Anatomy 0.000 claims description 8
- 201000010653 vesiculitis Diseases 0.000 claims description 8
- 210000002307 prostate Anatomy 0.000 claims description 7
- 230000003115 biocidal effect Effects 0.000 claims 1
- 230000030097 organ senescence Effects 0.000 claims 1
- 230000032683 aging Effects 0.000 abstract description 41
- 210000001672 ovary Anatomy 0.000 abstract description 24
- 230000036285 pathological change Effects 0.000 abstract description 24
- 231100000915 pathological change Toxicity 0.000 abstract description 24
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 abstract description 20
- 241000700159 Rattus Species 0.000 abstract description 18
- 210000000056 organ Anatomy 0.000 abstract description 14
- 238000000034 method Methods 0.000 abstract description 9
- 210000001835 viscera Anatomy 0.000 abstract description 9
- 241001523681 Dendrobium Species 0.000 abstract description 8
- 230000001575 pathological effect Effects 0.000 abstract description 7
- 230000003712 anti-aging effect Effects 0.000 abstract description 6
- 230000008569 process Effects 0.000 abstract description 6
- 238000012360 testing method Methods 0.000 abstract description 4
- 238000011161 development Methods 0.000 abstract description 3
- 230000018109 developmental process Effects 0.000 abstract description 3
- 238000011552 rat model Methods 0.000 abstract 2
- 230000001850 reproductive effect Effects 0.000 abstract 2
- 238000007689 inspection Methods 0.000 abstract 1
- 241000699670 Mus sp. Species 0.000 description 39
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 39
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 38
- 150000004676 glycans Chemical class 0.000 description 37
- 238000003809 water extraction Methods 0.000 description 35
- 102000019197 Superoxide Dismutase Human genes 0.000 description 30
- 108010012715 Superoxide dismutase Proteins 0.000 description 30
- 210000002966 serum Anatomy 0.000 description 27
- 210000004027 cell Anatomy 0.000 description 26
- 229940079593 drug Drugs 0.000 description 23
- 150000004804 polysaccharides Polymers 0.000 description 23
- 210000001519 tissue Anatomy 0.000 description 23
- 206010003694 Atrophy Diseases 0.000 description 21
- 230000037444 atrophy Effects 0.000 description 21
- 230000000694 effects Effects 0.000 description 21
- 210000004907 gland Anatomy 0.000 description 20
- 241001465754 Metazoa Species 0.000 description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 17
- 241000699666 Mus <mouse, genus> Species 0.000 description 16
- 239000013505 freshwater Substances 0.000 description 16
- 210000004369 blood Anatomy 0.000 description 14
- 239000008280 blood Substances 0.000 description 14
- 229920001282 polysaccharide Polymers 0.000 description 14
- 239000005017 polysaccharide Substances 0.000 description 14
- 239000000047 product Substances 0.000 description 14
- 206010020880 Hypertrophy Diseases 0.000 description 11
- 239000000284 extract Substances 0.000 description 11
- 210000003205 muscle Anatomy 0.000 description 11
- 210000004246 corpus luteum Anatomy 0.000 description 10
- 210000001541 thymus gland Anatomy 0.000 description 10
- 210000000981 epithelium Anatomy 0.000 description 9
- 239000000843 powder Substances 0.000 description 9
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 8
- 239000006286 aqueous extract Substances 0.000 description 8
- 241000208340 Araliaceae Species 0.000 description 7
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 7
- 235000003140 Panax quinquefolius Nutrition 0.000 description 7
- 239000003153 chemical reaction reagent Substances 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 235000008434 ginseng Nutrition 0.000 description 7
- 206010020718 hyperplasia Diseases 0.000 description 7
- 210000004185 liver Anatomy 0.000 description 7
- 210000000952 spleen Anatomy 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 6
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 6
- 230000037396 body weight Effects 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- 230000003203 everyday effect Effects 0.000 description 6
- 239000000706 filtrate Substances 0.000 description 6
- 238000003304 gavage Methods 0.000 description 6
- 239000007924 injection Substances 0.000 description 6
- 238000002347 injection Methods 0.000 description 6
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 6
- 210000003734 kidney Anatomy 0.000 description 6
- 230000002611 ovarian Effects 0.000 description 6
- 238000010992 reflux Methods 0.000 description 6
- 230000017423 tissue regeneration Effects 0.000 description 6
- 238000012449 Kunming mouse Methods 0.000 description 5
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 5
- 210000004556 brain Anatomy 0.000 description 5
- 230000001413 cellular effect Effects 0.000 description 5
- 230000034994 death Effects 0.000 description 5
- 230000000762 glandular Effects 0.000 description 5
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 5
- 230000008595 infiltration Effects 0.000 description 5
- 238000001764 infiltration Methods 0.000 description 5
- 230000003902 lesion Effects 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 210000004400 mucous membrane Anatomy 0.000 description 5
- 230000003647 oxidation Effects 0.000 description 5
- 238000007254 oxidation reaction Methods 0.000 description 5
- 210000002863 seminiferous tubule Anatomy 0.000 description 5
- 230000001568 sexual effect Effects 0.000 description 5
- 210000005239 tubule Anatomy 0.000 description 5
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 4
- 238000010171 animal model Methods 0.000 description 4
- 229910002092 carbon dioxide Inorganic materials 0.000 description 4
- 239000001569 carbon dioxide Substances 0.000 description 4
- 230000007123 defense Effects 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 229960003180 glutathione Drugs 0.000 description 4
- 210000002570 interstitial cell Anatomy 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 235000021590 normal diet Nutrition 0.000 description 4
- 230000007170 pathology Effects 0.000 description 4
- 229910052711 selenium Inorganic materials 0.000 description 4
- 239000011669 selenium Substances 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 230000023852 carbohydrate metabolic process Effects 0.000 description 3
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 230000002357 endometrial effect Effects 0.000 description 3
- FBPFZTCFMRRESA-GUCUJZIJSA-N galactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-GUCUJZIJSA-N 0.000 description 3
- 235000003969 glutathione Nutrition 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 208000030159 metabolic disease Diseases 0.000 description 3
- 238000010172 mouse model Methods 0.000 description 3
- 230000017074 necrotic cell death Effects 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 239000012188 paraffin wax Substances 0.000 description 3
- 230000002980 postoperative effect Effects 0.000 description 3
- 230000035755 proliferation Effects 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 210000000582 semen Anatomy 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 102000016938 Catalase Human genes 0.000 description 2
- 108010053835 Catalase Proteins 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- 108010070675 Glutathione transferase Proteins 0.000 description 2
- 102100029100 Hematopoietic prostaglandin D synthase Human genes 0.000 description 2
- 206010033122 Ovarian atrophy Diseases 0.000 description 2
- 239000004107 Penicillin G sodium Substances 0.000 description 2
- 102000003992 Peroxidases Human genes 0.000 description 2
- 210000000683 abdominal cavity Anatomy 0.000 description 2
- 102000011759 adducin Human genes 0.000 description 2
- 108010076723 adducin Proteins 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- 230000002605 anti-dotal effect Effects 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 210000005252 bulbus oculi Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- RNFNDJAIBTYOQL-UHFFFAOYSA-N chloral hydrate Chemical compound OC(O)C(Cl)(Cl)Cl RNFNDJAIBTYOQL-UHFFFAOYSA-N 0.000 description 2
- 229960002327 chloral hydrate Drugs 0.000 description 2
- 230000007850 degeneration Effects 0.000 description 2
- 230000018044 dehydration Effects 0.000 description 2
- 238000006297 dehydration reaction Methods 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 238000004043 dyeing Methods 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- AZHSSKPUVBVXLK-UHFFFAOYSA-N ethane-1,1-diol Chemical compound CC(O)O AZHSSKPUVBVXLK-UHFFFAOYSA-N 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 229930182830 galactose Natural products 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 210000003701 histiocyte Anatomy 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 230000003859 lipid peroxidation Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 230000007102 metabolic function Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 231100001043 ovarian atrophy Toxicity 0.000 description 2
- -1 oxygen free radical Chemical class 0.000 description 2
- 235000019369 penicillin G sodium Nutrition 0.000 description 2
- 229940056360 penicillin g Drugs 0.000 description 2
- 108040007629 peroxidase activity proteins Proteins 0.000 description 2
- 238000005502 peroxidation Methods 0.000 description 2
- 150000002978 peroxides Chemical class 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 238000006722 reduction reaction Methods 0.000 description 2
- 230000001172 regenerating effect Effects 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 239000008354 sodium chloride injection Substances 0.000 description 2
- 230000000920 spermatogeneic effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 210000001215 vagina Anatomy 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 102000016912 Aldehyde Reductase Human genes 0.000 description 1
- 108010053754 Aldehyde reductase Proteins 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 241000005787 Cistanche Species 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000190633 Cordyceps Species 0.000 description 1
- 244000293323 Cosmos caudatus Species 0.000 description 1
- 235000005956 Cosmos caudatus Nutrition 0.000 description 1
- 208000012239 Developmental disease Diseases 0.000 description 1
- 241000222336 Ganoderma Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 102000010445 Lactoferrin Human genes 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 102000010750 Metalloproteins Human genes 0.000 description 1
- 108010063312 Metalloproteins Proteins 0.000 description 1
- 241001448624 Miliaria Species 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 1
- 241000545442 Radix Species 0.000 description 1
- 102000002070 Transferrins Human genes 0.000 description 1
- 108010015865 Transferrins Proteins 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- GZCGUPFRVQAUEE-KCDKBNATSA-N aldehydo-D-galactose Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-KCDKBNATSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 210000002469 basement membrane Anatomy 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 238000010531 catalytic reduction reaction Methods 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000001447 compensatory effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 238000007323 disproportionation reaction Methods 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- 210000004696 endometrium Anatomy 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 210000003979 eosinophil Anatomy 0.000 description 1
- 210000000918 epididymis Anatomy 0.000 description 1
- 201000010063 epididymitis Diseases 0.000 description 1
- 230000009841 epithelial lesion Effects 0.000 description 1
- 230000008508 epithelial proliferation Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- XDDAORKBJWWYJS-UHFFFAOYSA-N glyphosate Chemical compound OC(=O)CNCP(O)(O)=O XDDAORKBJWWYJS-UHFFFAOYSA-N 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 150000002432 hydroperoxides Chemical class 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
- 235000021242 lactoferrin Nutrition 0.000 description 1
- 229940078795 lactoferrin Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 210000003584 mesangial cell Anatomy 0.000 description 1
- 210000000713 mesentery Anatomy 0.000 description 1
- 230000008558 metabolic pathway by substance Effects 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 210000002394 ovarian follicle Anatomy 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000000583 progesterone congener Substances 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 210000004061 pubic symphysis Anatomy 0.000 description 1
- 230000000384 rearing effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 210000004706 scrotum Anatomy 0.000 description 1
- ZKZBPNGNEQAJSX-UHFFFAOYSA-N selenocysteine Chemical group [SeH]CC(N)C(O)=O ZKZBPNGNEQAJSX-UHFFFAOYSA-N 0.000 description 1
- 239000002893 slag Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000007447 staining method Methods 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 210000001562 sternum Anatomy 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 210000003684 theca cell Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 210000003708 urethra Anatomy 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 229940033282 vitamin b6 2 mg Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000008215 water for injection Substances 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
组别 | 子宫直径(显微测量)×10-4mm |
假手术组 | 1615±375 |
模型组 | 1117±147** |
高剂量组 | 1305±186*# |
组别 | SOD活性单位(U/ml) | MDA含量(nmol/ml) |
假手术组 | 139.04±51.93 | 12.77±4.78 |
模型组 | 117.67±22.63 | 13.70±4.10 |
阳性组 | 161.39±16.79## | 10.49±1.43 |
铁皮石斛高剂量组 | 169.00±30.96## | 10.65±1.98 |
铁皮石斛低剂量组 | 143.17±16.77# | 11.47±2.00 |
SOD活性单位(u/ml) | MDA含量(nmol/ml) | |
假手术组 | 105.76±21.26 | 10.68±1.23 |
模型组 | 86.21±23.98 | 13.20±3.80 |
阳性组 | 114.44±22.77## | 9.53±1.12# |
铁皮石斛高剂量组 | 124.35±21.64## | 9.05±1.70## |
铁皮石斛低剂量组 | 126.26±17.82## | 8.78±1.66## |
组别 | 胸腺系数(%) | 脾系数(%) | 肾系数(%) | 肝系数(%) | 脑系数(%) |
正常组 | 1.74±0.57** | 2.55±0.52** | 13.00±2.05 | 37.99±2.01* | 10.25±0.84* |
模型组 | 1.05±0.36 | 6.73±2.04 | 13.24±2.29 | 41.51±4.66* | 10.85±0.67 |
阳性组 | 1.27±0.46 | 4.31±1.32* | 13.31±1.48 | 37.34±3.80 | 11.02±0.54 |
鲜-榨汁组 | 1.88±0.28** | 8.82±2.10 | 13.04±1.86 | 41.39±2.66 | 10.67±0.99 |
鲜-水提组 | 1.58±0.38** | 6.59±2.06 | 12.11±2.07 | 37.28±5.55 | 11.43±0.96 |
干-水提组 | 1.94±0.40** | 7.27±3.21 | 14.30±2.64 | 43.23±5.88 | 11.57±1.63 |
粗多糖组 | 1.59±0.50* | 8.71±2.86 | 13.97±1.34 | 44.46±4.84 | 10.59±0.54 |
组别 | 胸腺系数(%) | 脾系数(%) | 肾系数(%) | 肝系数(%) | 脑系数(%) |
正常组 | 2.84±0.60* | 4.59±1.16** | 9.88±1.83 | 38.14±4.98 | 14.67±1.47* |
模型组 | 2.34±0.26 | 6.94±1.61 | 10.11±1.12 | 40.10±4.63 | 13.23±0.64 |
阳性组 | 2.65±0.68 | 6.23±1.69 | 10.95±1.16 | 38.88±4.42 | 13.03±1.09 |
鲜-榨汁组 | 2.72±0.45* | 5.15±2.43 | 9.80±1.32 | 36.59±5.51 | 13.50±1.48 |
鲜-水提组 | 2.89±0.64* | 8.10±1.72 | 10.08±1.25 | 38.01±4.82 | 13.74±0.93 |
干-水提组 | 2.67±0.40* | 7.74±3.67 | 10.02±0.99 | 38.69±3.04 | 13.10±0.92 |
粗多糖组 | 3.05±0.28** | 6.58±2.13 | 10.34±0.63 | 36.35±3.13* | 12.42±0.71* |
组别 | SOD含量(U/mgprot) |
正常组 | 170.13±16.65** |
模型组 | 139.31±15.85 |
阳性组 | 150.60±13.41 |
鲜-榨汁组 | 164.27±36.20* |
鲜-水提组 | 168.75±15.04* |
干-水提组 | 141.94±22.15 |
粗多糖组 | 147.73±23.17 |
组别 | SOD含量(U/mgprot) |
正常组 | 159.03±9.35 |
模型组 | 152.55±8.21 |
阳性组 | 171.23±17.72** |
鲜-榨汁组 | 169.76±4.92** |
鲜-水提组 | 163.77±21.91** |
干-水提组 | 175.82±3.66** |
粗多糖组 | 182.52±14.16** |
组别 | T-AOC含量(单位/ml) |
正常组 | 4.96±1.97 |
模型组 | 4.79±2.93 |
阳性组 | 5.82±2.78 |
鲜-榨汁组 | 3.60±1.15 |
鲜-水提组 | 3.05±2.85 |
干-水提组 | 5.04±3.06 |
粗多糖组 | 6.23±3.26 |
组别 | T-AOC含量(单位/ml) |
正常组 | 3.43±1.68* |
模型组 | 1.17±2.00 |
阳性组 | 2.14±5.23 |
鲜-榨汁组 | 2.78±1.45* |
鲜-水提组 | 3.05±2.85 |
干-水提组 | 2.39±2.29 |
粗多糖组 | 3.18±1.52* |
GSH-PX含量(酶活力单位) | |
正常组 | 780.00±300.84 |
模型组 | 786.00±155.19 |
阳性组 | 1007.25±161.68** |
鲜-榨汁组 | 1488.67±58.82** |
鲜-水提组 | 1193.33±153.07** |
干-水提组 | 1450.67±105.12** |
粗多糖组 | 912.00±158.75 |
GSH-PX含量(酶活力单位) | |
正常组 | 997.71±263.63 |
模型组 | 850.80±136.91 |
阳性组 | 1200.00±180.25* |
鲜-榨汁组 | 1292.67±204.6** |
鲜-水提组 | 1193.33±153.07* |
干-水提组 | 888.75±334.90 |
粗多糖组 | 1092.75±114.54 |
正常组 | 模型组 | 阳性组 | 鲜榨汁 | 干水提 | 鲜水提 | 粗多糖 | |
- | 15 | 11 | 9 | 9 | 14 | 10 | 14 |
+ | 0 | 3 | 3 | 6 | 1 | 5 | 1 |
++ | 0 | 1 | 3 | 0 | 0 | 0 | 0 |
+++ | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
正常组 | 模型组 | 阳性组 | 鲜榨汁 | 干水提 | 鲜水提 | 粗多糖 | |
- | 9 | 0 | 4 | 9 | 9 | 8 | 6 |
+ | 0 | 0 | 2 | 0 | 0 | 1 | 2 |
++ | 0 | 0 | 3 | 0 | 0 | 0 | 1 |
+++ | 0 | 9 | 0 | 0 | 0 | 0 | 0 |
** | ** | ** | ** | ** | ** |
正常组 | 模型组 | 阳性组 | 鲜榨汁 | 干水提 | 鲜水提 | 粗多糖 | |
- | 12 | 9 | 10 | 11 | 12 | 11 | 10 |
+ | 0 | 3 | 2 | 1 | 0 | 1 | 2 |
++ | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
+++ | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
卵巢系数(‰) | 子宫系数(‰) | |
青年组 | 0.69±0.16** | 2.99±0.86* |
衰老组 | 0.48±0.16 | 3.71±0.97 |
榨汁组 | 0.56±0.31 | 2.48±0.79** |
多糖组 | 0.58±0.50 | 2.37±0.76** |
子官 | 卵巢 | |
青年组 | 0.00±0.00** | 0.00±0.00** |
衰老组 | 2.83±1.60 | 4.33±2.34 |
榨汁组 | 1.17±0.75* | 2.75±1.26 |
多糖组 | 1.33±1.21* | 2.60±1.95 |
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210010975.3A CN102552698B (zh) | 2012-01-16 | 2012-01-16 | 铁皮石斛的药用用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210010975.3A CN102552698B (zh) | 2012-01-16 | 2012-01-16 | 铁皮石斛的药用用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102552698A CN102552698A (zh) | 2012-07-11 |
CN102552698B true CN102552698B (zh) | 2015-01-07 |
Family
ID=46400152
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210010975.3A Expired - Fee Related CN102552698B (zh) | 2012-01-16 | 2012-01-16 | 铁皮石斛的药用用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102552698B (zh) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103585473A (zh) * | 2013-11-14 | 2014-02-19 | 东莞广州中医药大学中医药数理工程研究院 | 铁皮石斛防治大脑衰老的新用途 |
CN107496885A (zh) * | 2017-09-29 | 2017-12-22 | 南京仙草堂生物科技有限公司 | 一种治疗骨质疏松的铁皮石斛中药制剂的制备方法 |
CN107485685A (zh) * | 2017-09-29 | 2017-12-19 | 南京仙草堂生物科技有限公司 | 一种基于铁皮石斛的中药制剂的制备方法 |
CN109985058A (zh) * | 2017-12-29 | 2019-07-09 | 暨南大学 | 石斛多糖在制备防治砷中毒致生殖损伤药物中的应用 |
CN109985059A (zh) * | 2017-12-29 | 2019-07-09 | 暨南大学 | 石斛多糖在制备癌症化疗后生殖损伤恢复药物中的应用 |
CN109985061B (zh) * | 2017-12-29 | 2021-07-27 | 暨南大学 | 石斛多糖在制备预防和/或治疗前列腺增生药物中的应用 |
CN109985060A (zh) * | 2017-12-29 | 2019-07-09 | 暨南大学 | 石斛多糖在制备预防或恢复化疗后生殖损伤的药物中应用 |
CN110694005A (zh) * | 2018-07-09 | 2020-01-17 | 成都百裕制药股份有限公司 | 一种预防或治疗性功能障碍的组合物及其用途 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101273709A (zh) * | 2008-05-14 | 2008-10-01 | 南京养颐堂生物科技实业有限公司 | 一种铁皮石斛快繁的组培方法 |
CN102008654B (zh) * | 2010-12-12 | 2012-04-04 | 杨军 | 一种铁皮石斛鲜汁原液的制作方法 |
-
2012
- 2012-01-16 CN CN201210010975.3A patent/CN102552698B/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN102552698A (zh) | 2012-07-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102552698B (zh) | 铁皮石斛的药用用途 | |
CN105636603A (zh) | 包含蓝靛果果实的提取物作为活性成分的预防或治疗甲状腺疾病的药物组合物 | |
CN102907663A (zh) | 一种缓解体力疲劳的保健食品组合物及其制备方法 | |
CN109718303A (zh) | 提高女性卵巢功能养颜美容改善女性皮肤的中药组合物 | |
CN110200282A (zh) | 用于提高女性生育机能的保健食品及其制备方法 | |
CN104258139A (zh) | 一种用于防治慢性型猪瘟疫的药物组合物及其制备方法 | |
CN110140960A (zh) | 一种改善男性勃起功能障碍、抗疲劳的组合物及制剂、饮液 | |
CN101647951B (zh) | 一种中药组合物及其制备方法和应用 | |
CN101856418B (zh) | 防治肾炎的药物制剂及其制备方法 | |
CN108434239A (zh) | 补气血抗疲劳口服液及其制备方法 | |
CN112870304A (zh) | 一种可有效助眠的口服液及其制备方法 | |
CN107912773A (zh) | 一种用于缓解体力疲劳的制剂 | |
WO2023125797A1 (zh) | 一种中药组合物及其制备方法与应用 | |
CN101618087B (zh) | 一种具有改善更年期功能的保健食品 | |
CN106036173A (zh) | 一种春季用雏鸭饲料添加剂 | |
CN109985059A (zh) | 石斛多糖在制备癌症化疗后生殖损伤恢复药物中的应用 | |
CN103445176A (zh) | 增强免疫力保健食品及其制备方法 | |
CN101336705A (zh) | 保健食品及其制备方法 | |
CN100473416C (zh) | 治疗胃病的中药制剂及其制备方法 | |
CN105030952B (zh) | 一种组合物在制备预防尿结石药物中的应用 | |
CN110101813A (zh) | 一种治疗肾阳虚牡蛎组合物口服液制备方法及其应用 | |
CN103735600B (zh) | 一种保健品 | |
CN106581176A (zh) | 一种治疗不孕不育的中药组合物和制备方法及其用途 | |
KR101855820B1 (ko) | 간 기능 개선 및 스태미나 증진을 위한 건강식품 조성물 | |
CN106344655A (zh) | 一种具有降血糖功效的中药组合物及其制作方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
DD01 | Delivery of document by public notice |
Addressee: GUANGDONG YONGSHENGYUAN BIO-TECH Co.,Ltd. Document name: Notification to Pay the Fees |
|
C56 | Change in the name or address of the patentee | ||
CP02 | Change in the address of a patent holder |
Address after: The new Fengzhen 515736 Guangdong city of Chaozhou province Raoping County village of Tai Hang Yang Rong Patentee after: GUANGDONG YONGSHENGYUAN BIO-TECH Co.,Ltd. Address before: 518048 Guangdong city of Shenzhen province Futian District Fuhua road three Century Center of excellence No. 1 building 21 layer Patentee before: GUANGDONG YONGSHENGYUAN BIO-TECH Co.,Ltd. |
|
PP01 | Preservation of patent right | ||
PP01 | Preservation of patent right |
Effective date of registration: 20180914 Granted publication date: 20150107 |
|
PD01 | Discharge of preservation of patent | ||
PD01 | Discharge of preservation of patent |
Date of cancellation: 20220914 Granted publication date: 20150107 |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150107 |